Lexaria Bioscience Corp Live Stock Price Today, Share Analysis and Chart

Name: Lexaria Bioscience Corp: Is Infosys Ltd. worth buying?
Item: Lexaria Bioscience Corp
Rating: 1.46475
Author: Trendlyne DVM scores

about

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability...

0.73 0.00 (0.00%)

61.58% Fall from 52W High

164.6K

XNAS Volume

XNAS 10 Mar, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

11.0 / 100

Technically Neutral

47.6 / 100

1Yr Price target upside is 414%

2 analysts

Lexaria Bioscience Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lexaria Bioscience Corp Live Stock Price Today, Share Analysis and Chart

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability...

61.58% Fall from 52W High

SWOT Analysis

Lexaria Bioscience Corp Live Price Chart